Inhibitory effect of cyclosporin A on growth and collagen synthesis of rat cardiac fibroblasts induced by arginine vasopressin

Yaoxue Xuebao

Volumn 41, Issue 11, 2006, Pages 1044-1049

  Shang, Fu Jun ^a   Zhao, Lian You ^a   Zheng, Qiang Sun ^a   Wang, Jie Pin ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arginine vasopressin; Cardiac fibroblasts; Cell growth; Collagen synthesis; Cyclosporin A

Indexed keywords

ARGIPRESSIN; CALCINEURIN; COLLAGEN; CYCLOSPORIN; HYDROXYPROLINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; HEART MUSCLE; METABOLISM; NEWBORN; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ARGININE VASOPRESSIN; CALCINEURIN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HYDROXYPROLINE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33846148315     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schillaci G, Verdecchia P, Porcellati C, et al. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension [J]. Hypertension, 2000,35:580-586.
2. 2+-ATPase activity in renovascular hypertensive rats [J]. Acta Pharm Sin, 2002,37:401-404.
3. Brown RD, Ambler SK, Mitchell MD, et al. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure [J]. Annu Rev Pharmacol Toxicol, 2005,45: 657-687.
4. Booz GW, Baker KM. Molecular signaling mechanisms controlling growth and function of cardiac fibroblasts [J]. Cardiovas Res, 1995,30:537-543.
5. Schnee JM, Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis [J]. Cardiovasc Res, 2000,46:264-268.
6. Fan YH, Zhao LY, Zheng QS, et al. Arginine vasopressin-induced nitric oxide content changes in cultured cardiac fibroblasts and its relation to nuclear factor-kappaB [J]. Acta Physiol Sin, 2003,55:417-421.
7. Berridge MJ, Bootman MD, Lipp P. Calcium: a life and death signal [J]. Nature, 1998,395:645-648.
8. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin dependent transcriptional pathway for cardiac hypertrophy [J]. Cell, 1998,93:215-228.
9. Taigen T, Windt LJ, Lim HW, et al. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy [J]. Proc Natl Acad Sci USA, 2000,97: 1196-1201.
10. Takeda Y, Yoneda T, Demura M, et al. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy [J]. Circulation, 2002,105:677-679.
11. Saito T, Fukuzawa J, Osaki J, et al. Roles of calcineurin and calcium / calmodulin dependent protein kinase II in pressure overload-induced cardiac hypertrophy [J]. J Mol Cell Cardiol, 2003,35:1153-1160.
12. 1 receptor [J]. J Cardiovasc Pharmacol, 2003,42:132-135.
13. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues [J]. Clin Biochem, 1996,29:225-229.
14. Zhou CL, Wei Q, Li H, et al. Study of temporal and spatial changes of calcineurin activity in brains of patients with Alzheimer [J]. J Cap Inst Med, 1998,19:23-25.
15. 2 receptor mRNA in rats [J]. Eur J Pharmacol, 1994, 267:71-75.
16. Tomono M, Toyoshima K, Ito M, et al. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts [J]. Arch Biochem Biophys, 1998,353:374-378.